4//SEC Filing
GREEN JOHN B 4
Accession 0000899243-19-028270
CIK 0001399529other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 8:00 PM ET
Size
9.0 KB
Accession
0000899243-19-028270
Insider Transaction Report
Form 4
GREEN JOHN B
Interim CFO
Transactions
- Exercise/Conversion
Common Stock
2019-11-25$5.45/sh+12,500$68,125→ 23,198 total - Sale
Common Stock
2019-11-25$24.95/sh−12,500$311,875→ 10,698 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-11-25−12,500→ 227,500 totalExercise: $5.45Exp: 2026-04-14→ Common Stock (12,500 underlying)
Footnotes (3)
- [F1]Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2018.
- [F3]The option vested 25% after the first year anniversary of the vesting start date of April 14, 2016 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001243847
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 8:00 PM ET
- Size
- 9.0 KB